Company data
Artiva Biotherapeutics, Inc. employees and revenue per employee
ARTV · Biotechnology · $203M market cap
Artiva Biotherapeutics, Inc. had 89 employees at the end of fiscal Dec 2024. Revenue for the year was $251,000, or $3K per employee.
Employees
89
Revenue
$251,000
Revenue / employee
$3K
Peer median $457K
Rank in industry
107 of 110
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Only one fiscal year on file so far, so there is no trend to draw yet.
Artiva Biotherapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| STTK Shattuck Labs, Inc. | 40 | $1.0M | $25K | Contracting |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| ABSI Absci Corporation | 140 | $2.8M | $20K | Contracting |
| INBX Inhibrx Biosciences Inc. | 109 | $1.3M | $12K | Leaner |
| NGNE Neurogene Inc. | 107 | $925,000 | $9K | — |
| CLDX Celldex Therapeutics, Inc. | 198 | $1.5M | $8K | Hiring into decline |
| ARTV Artiva Biotherapeutics, Inc. | 89 | $251,000 | $3K | — |
| AVTX Avalo Therapeutics, Inc. | 33 | $59,000 | $2K | Hiring into decline |
| LYEL Lyell Immunopharma, Inc. | 161 | $36,000 | $224 | Contracting |
Questions about Artiva Biotherapeutics, Inc.
- How many employees does Artiva Biotherapeutics, Inc. have?
- Artiva Biotherapeutics, Inc. reported 89 employees for the fiscal year ending Dec 2024, in the annual report it filed on March 24, 2025.
- What is Artiva Biotherapeutics, Inc.'s revenue per employee?
- Artiva Biotherapeutics, Inc. brought in $251,000 of revenue in fiscal Dec 2024, which is $3K per employee. That ranks 107 of 110 companies we track in Biotechnology, where the median is $457K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare ARTV with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Artiva Biotherapeutics, Inc.'s annual reports (Form 10-K), latest filed March 24, 2025. This is data, not a recommendation to buy or sell ARTV.